慢性心力衰竭患者血清TBA水平与心室重构及炎症反应的相关性[J]. 张蕾;李跃;何立娟;刘美清;曾小莉;袁慧.中国循证心血管医学杂志,2018(12)

半乳糖凝集素-3、可溶性基质溶素-2检测对心力衰竭诊断的相关性研究[J]. 徐晓晓;贾如意;王涛;刘强;甄臻.中国循环杂志,2016(09)

Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction[J]. Albar Zainab;Albakri Marwah;Hajjari Jamal;Karnib Mohamad;Janus Scott E.;Al-Kindi Sadeer G..The American Journal of Cardiology,2022

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials[J]. Lin Yaowang;Wu Meishan;Liao Bihong;Pang Xinli;Chen Qiuling;Yuan Jie;Dong Shaohong.Frontiers in Pharmacology,2021

Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction[J]. Naruse Hiroyuki;Ishii Junnichi;Takahashi Hiroshi;Kitagawa Fumihiko;Sakaguchi Eirin;Nishimura Hideto;Kawai Hideki;Muramatsu Takashi;Harada Masahide;Yamada Akira;Fujiwara Wakaya;Hayashi Mutsuharu;Motoyama Sadako;Sarai Masayoshi;Watanabe Eiichi;Ito Hiroyasu;Ozaki Yukio;Izawa Hideo.Journal of Clinical Medicine,2021

Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.[J]. Baral Nischit;Gautam Swotantra;Yadav Saroj A;Poudel Sangeeta;Adhikari Govinda;Rauniyar Rohit;Savarapu Pramod;Katel Anjan;Paudel Anish C;Parajuli Prem R.Cureus,2021

Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction[J]. Rocio Blanco;Giuseppe Ambrosio;Cesar Belziti;Luciano Lucas;Anibal Arias;Antonella D'Antonio;Pablo Oberti;Erberto Carluccio;Rodolfo Pizarro.International Journal of Cardiology,2020

D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.[J]. Xiaoyuan Zhang;Shanjie Wang;Jinxin Liu;Yini Wang;Hengxuan Cai;Duolao Wang;Shaohong Fang;Bo Yu.Heart (British Cardiac Society),2020

The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.[J]. Markousis-Mavrogenis George;Tromp Jasper;Ouwerkerk Wouter;Devalaraja Matt;Anker Stefan D;Cleland John G;Dickstein Kenneth;Filippatos Gerasimos S;van der Harst Pim;Lang Chim C;Metra Marco;Ng Leong L;Ponikowski Piotr;Samani Nilesh J;Zannad Faiez;Zwinderman Aeilko H;Hillege Hans L;van Veldhuisen Dirk J;Kakkar Rahul;Voors Adriaan A;van der Meer Peter.European journal of heart failure,2019

C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction[J]. Patrícia Lourenço;Joana Pereira;Ana Ribeiro;João Ferreira-Coimbra;Isaac Barroso;João-Tiago Guimarães;Adelino Leite-Moreira;Paulo Bettencourt.Journal of Cardiovascular Medicine,2019

Predicting the risk of venous thromboembolism in patients hospitalized with heart failure.[J]. Mebazaa Alexandre;Spiro Theodore E;Büller Harry R;Haskell Lloyd;Hu Dayi;Hull Russell;Merli Geno;Schellong Sebastian W;Spyropoulos Alex C;Tapson Victor F;De Sanctis Yoriko;Cohen Alexander T.Circulation,2014

Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure.[J]. Jug Borut;Salobir Barbara Guzic;Vene Nina;Sebestjen Miran;Sabovic Miso;Keber Irena.Heart and vessels,2009

A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.[J]. Tello-Montoliu A;Marín F;Roldán V;Mainar L;López M T;Sogorb F;Vicente V;Lip G Y H.Journal of internal medicine,2007